Az adenozin és rokonvegyületei di-n-butilón(IV) komplexeinek eloállítása és spektroszkópiás vizsgálata

Translated title of the contribution: Preparation and spectroscopic studies of diorganotin(IV) complexes with adenosine and related compounds

K. Gajda-Schrantz, L. Nagy, E. Kuzmann, A. A. Christy, H. Barátné-Jankovics, E. Sletten, A. Vértes

Research output: Contribution to journalArticle

Abstract

Nine complexes of adenosine and related compounds (adenosine-5′-monophosphate, adenosine-5′-triphosphate, 1-methyladenosine, pyridoxal-5-phosphate and β-nicotinamide-adeninedinucleotide-phosphoric acid) with di-n-butyltin(IV) oxide and/or di-n-butytin(IV) dichloride were prepared in the solid state. The compositions of the complexes were determined by standard analytical methods. It was found that the complexes contain organotin(IV) moiety and the ligand in a ratio of 1:1 or 2:1. The FTIR spectra demonstrated that di-n-butyltin(IV) oxide reacts with the D-ribose moiety of the ligands, while di-n-butyltin(IV) dichloride is co-ordinated to the deprotonated phosphate group. The basic part of the ligands does not participate directly in complex formation. Comparison of the experimental Mössbauer ΔE values with those calculated on the basis of the PQS concept revealed that the organotin(IV) moiety has trigonal-bipyramidal, octahedral and in some cases tetrahedral geometry also. Some of the complexes contain the organotin(IV) cation in two different surroundings.

Original languageHungarian
Pages (from-to)119-130
Number of pages12
JournalActa Pharmaceutica Hungarica
Volume70
Issue number3-6
Publication statusPublished - 2000

Fingerprint

Adenosine
Ligands
Oxides
Pyridoxal Phosphate
Ribose
Niacinamide
Fourier Transform Infrared Spectroscopy
Cations
Adenosine Triphosphate
Phosphates
di-n-butyltin
1-methyladenosine
dibutyldichlorotin
phosphoric acid

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Az adenozin és rokonvegyületei di-n-butilón(IV) komplexeinek eloállítása és spektroszkópiás vizsgálata. / Gajda-Schrantz, K.; Nagy, L.; Kuzmann, E.; Christy, A. A.; Barátné-Jankovics, H.; Sletten, E.; Vértes, A.

In: Acta Pharmaceutica Hungarica, Vol. 70, No. 3-6, 2000, p. 119-130.

Research output: Contribution to journalArticle

@article{313ac6a2934344b3ab3c4c2359de5d67,
title = "Az adenozin {\'e}s rokonvegy{\"u}letei di-n-butil{\'o}n(IV) komplexeinek elo{\'a}ll{\'i}t{\'a}sa {\'e}s spektroszk{\'o}pi{\'a}s vizsg{\'a}lata",
abstract = "Nine complexes of adenosine and related compounds (adenosine-5′-monophosphate, adenosine-5′-triphosphate, 1-methyladenosine, pyridoxal-5-phosphate and β-nicotinamide-adeninedinucleotide-phosphoric acid) with di-n-butyltin(IV) oxide and/or di-n-butytin(IV) dichloride were prepared in the solid state. The compositions of the complexes were determined by standard analytical methods. It was found that the complexes contain organotin(IV) moiety and the ligand in a ratio of 1:1 or 2:1. The FTIR spectra demonstrated that di-n-butyltin(IV) oxide reacts with the D-ribose moiety of the ligands, while di-n-butyltin(IV) dichloride is co-ordinated to the deprotonated phosphate group. The basic part of the ligands does not participate directly in complex formation. Comparison of the experimental M{\"o}ssbauer ΔE values with those calculated on the basis of the PQS concept revealed that the organotin(IV) moiety has trigonal-bipyramidal, octahedral and in some cases tetrahedral geometry also. Some of the complexes contain the organotin(IV) cation in two different surroundings.",
author = "K. Gajda-Schrantz and L. Nagy and E. Kuzmann and Christy, {A. A.} and H. Bar{\'a}tn{\'e}-Jankovics and E. Sletten and A. V{\'e}rtes",
year = "2000",
language = "Hungarian",
volume = "70",
pages = "119--130",
journal = "Acta Pharmaceutica Hungarica",
issn = "0001-6659",
publisher = "Magyar Gyogyszereszeti Tarsasag",
number = "3-6",

}

TY - JOUR

T1 - Az adenozin és rokonvegyületei di-n-butilón(IV) komplexeinek eloállítása és spektroszkópiás vizsgálata

AU - Gajda-Schrantz, K.

AU - Nagy, L.

AU - Kuzmann, E.

AU - Christy, A. A.

AU - Barátné-Jankovics, H.

AU - Sletten, E.

AU - Vértes, A.

PY - 2000

Y1 - 2000

N2 - Nine complexes of adenosine and related compounds (adenosine-5′-monophosphate, adenosine-5′-triphosphate, 1-methyladenosine, pyridoxal-5-phosphate and β-nicotinamide-adeninedinucleotide-phosphoric acid) with di-n-butyltin(IV) oxide and/or di-n-butytin(IV) dichloride were prepared in the solid state. The compositions of the complexes were determined by standard analytical methods. It was found that the complexes contain organotin(IV) moiety and the ligand in a ratio of 1:1 or 2:1. The FTIR spectra demonstrated that di-n-butyltin(IV) oxide reacts with the D-ribose moiety of the ligands, while di-n-butyltin(IV) dichloride is co-ordinated to the deprotonated phosphate group. The basic part of the ligands does not participate directly in complex formation. Comparison of the experimental Mössbauer ΔE values with those calculated on the basis of the PQS concept revealed that the organotin(IV) moiety has trigonal-bipyramidal, octahedral and in some cases tetrahedral geometry also. Some of the complexes contain the organotin(IV) cation in two different surroundings.

AB - Nine complexes of adenosine and related compounds (adenosine-5′-monophosphate, adenosine-5′-triphosphate, 1-methyladenosine, pyridoxal-5-phosphate and β-nicotinamide-adeninedinucleotide-phosphoric acid) with di-n-butyltin(IV) oxide and/or di-n-butytin(IV) dichloride were prepared in the solid state. The compositions of the complexes were determined by standard analytical methods. It was found that the complexes contain organotin(IV) moiety and the ligand in a ratio of 1:1 or 2:1. The FTIR spectra demonstrated that di-n-butyltin(IV) oxide reacts with the D-ribose moiety of the ligands, while di-n-butyltin(IV) dichloride is co-ordinated to the deprotonated phosphate group. The basic part of the ligands does not participate directly in complex formation. Comparison of the experimental Mössbauer ΔE values with those calculated on the basis of the PQS concept revealed that the organotin(IV) moiety has trigonal-bipyramidal, octahedral and in some cases tetrahedral geometry also. Some of the complexes contain the organotin(IV) cation in two different surroundings.

UR - http://www.scopus.com/inward/record.url?scp=0034495477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034495477&partnerID=8YFLogxK

M3 - Article

C2 - 11379018

AN - SCOPUS:0034495477

VL - 70

SP - 119

EP - 130

JO - Acta Pharmaceutica Hungarica

JF - Acta Pharmaceutica Hungarica

SN - 0001-6659

IS - 3-6

ER -